眼部合并症与多焦点人工晶状体植入术后长期患者报告结局指标的关联
回顾性临床队列研究纳入260例双眼植入衍射型多焦点人工晶状体且术后屈光正视、随访超过3年的患者,评估眼部合并症与长期患者报告结局指标的关联。有合并症眼在各距离裸眼视力、斯特列尔比、明视与暗视对比敏感度及VF-14评分均更差,干眼症、既往角膜屈光手术、玻璃体混浊和黄斑病变与较低VF-14评分独立相关。
要点
- 有眼部合并症眼各距离裸眼视力、斯特列尔比及明视和暗视对比敏感度均显著更差。
- 有合并症眼VF-14评分显著更低(87.1±13.8 vs 95.6±5.1,P < .001),眩光主诉更多。
- 干眼症、既往角膜屈光手术、玻璃体混浊和黄斑病变与较低VF-14评分独立相关。
核心结论
- 眼部合并症尤其干眼症和玻璃体混浊可引起波动性视觉干扰,与衍射型多焦点人工晶状体植入术后患者报告结局指标更大损害相关。
研究设计与样本
- 回顾性临床队列研究,纳入260例双眼植入衍射型多焦点人工晶状体、术后屈光正视且随访超过3年的患者。
主要发现
- 有合并症眼各距离裸眼视力均显著更差(均P < .001)。
- 有合并症眼斯特列尔比更低(0.034±0.023 vs 0.042±0.027,P < .001)。
- 有合并症眼明视对比敏感度更低(1.33±0.21 vs 1.40±0.18 AULCSF,P = .001),暗视对比敏感度也更低(1.01±0.20 vs 1.07±0.17 AULCSF,P < .001)。
- 有合并症眼VF-14评分显著更低(87.1±13.8 vs 95.6±5.1,P < .001),眩光主诉更多(13.6±25.0 vs 8.6±19.7,P = .015)。
- 校正年龄、性别、合并眼部疾病和多焦点人工晶状体类型后,干眼症、既往屈光手术、玻璃体混浊和黄斑病变与较低VF-14评分独立相关(均P < .001);干眼症(B = 18.0,95% CI 8.4-27.6,P < .001)和玻璃体混浊(B = 21.1,95% CI 0.0-42.2,P = .050)与更高整体视觉干扰评分相关;合并症负担增加、泪膜破裂时间缩短(r = 0.207,P = .005)和双侧黄斑病变(P < .001)进一步与更差VF-14评分相关。
关键数值与推荐
- 有合并症眼VF-14评分为87.1±13.8,无合并症眼为95.6±5.1(P < .001)。
- 有合并症眼斯特列尔比为0.034±0.023,无合并症眼为0.042±0.027(P < .001)。
- 有合并症眼明视AULCSF为1.33±0.21,无合并症眼为1.40±0.18(P = .001);暗视AULCSF为1.01±0.20 vs 1.07±0.17(P < .001)。
- 有合并症眼眩光评分为13.6±25.0,无合并症眼为8.6±19.7(P = .015)。
- 干眼症与整体视觉干扰评分相关(B = 18.0,95% CI 8.4-27.6,P < .001),玻璃体混浊与之相关(B = 21.1,95% CI 0.0-42.2,P = .050)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the association of ocular comorbidities on long-term patient-reported outcome measures (PROMs) in patients bilaterally implanted with diffractive multifocal intraocular lenses (MFIOLs). DESIGN: Retrospective clinical cohort study. SUBJECTS: A total of 260 patients who underwent bilateral implantation of MFIOLs with postoperative emmetropia and follow-up exceeding 3 years. METHODS: Uncorrected visual acuities at near, intermediate and distance, contrast sensitivities, optical quality, spectacle-independent Visual Function Index (VF-14) questionnaire scores and dysphotopsia (graded 0-100 for glare, halos, and starburst) were measured. Ocular comorbidities included dry eye disease, prior corneal refractive surgery, vitreous opacities, macular disease, nonproliferative diabetic retinopathy, and glaucoma. MAIN OUTCOME MEASURES: VF-14 scores at 3 years. RESULTS: Eyes with comorbidities showed significantly worse uncorrected visual acuities at all distances (all P < .001), lower Strehl ratio (0.034±0.023 vs 0.042±0.027, P < .001), and reduced contrast sensitivity under both photopic (1.33±0.21 vs 1.40±0.18 area under the log contrast sensitivity function [AULCSF], P = .001) and mesopic conditions (1.01±0.20 vs 1.07±0.17 AULCSF, P < .001) compared with eyes without comorbidities. VF-14 scores were significantly lower in eyes with comorbidities (87.1±13.8 vs 95.6±5.1; P < .001), with more glare reported (13.6±25.0 vs 8.6±19.7; P = .015). On multivariable analysis with age, sex, concomitant ocular comorbidities, and MFIOL type adjustment, dry eye disease, prior refractive surgery, vitreous opacities, and macular disease were independently associated with lower VF-14 scores (all P < .001). Dry eye disease (B = 18.0, 95% CI 8.4-27.6, P < .001) and vitreous opacities (B = 21.1, 95% CI 0.0-42.2, P = .050) were associated with higher dysphotopsia overall scores. Increasing comorbidity burden, shorter tear film break-up time (r = 0.207, P = .005), and bilateral macular disease (P < .001) were further associated with worse VF-14 scores. CONCLUSIONS: Ocular comorbidities, particularly dry eye disease and vitreous opacities, which cause fluctuating visual disturbances, were associated with greater impairment in PROMs following diffractive MFIOL implantation.
引用
- Tuuminen R, Jeon S. Association of Ocular Comorbidities on Long-term Patient-Reported Outcome Measures After Multifocal Intraocular Lens Implantation. Am J Ophthalmol. 2025. PMID: 41061947. doi:10.1016/j.ajo.2025.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。